Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2020;5(1):1712.DOI: 10.25107/2474-1663-v5-id1712

Total Pancreatectomy with Spleen Preservation for Distal Cholangiocarcinoma Synchronous with Multifocal IPMNs and a Neuroendocrine Tumour of the Pancreas

Abdelhak Lamara, Badreddine Nini, Mohamed Boukhane1, Sid Ahmed Medjahdi, Amel Soualmia, Abdelkrim Rehamnia, Nacereddine Lemaici and Saliha Benyarbah

Department of General Surgery, Regional Military University Hospital of Constantine, Algeria National Transplant Coordination, Algeria Department of Gastroenterology, Regional Military University Hospital of Constantine, Algeria Department of Pathology, Regional Military University Hospital of Constantine, Algeria

*Correspondance to: Abdelhak Lamara 

 PDF  Full Text Case Report | Open Access

Abstract:

Introduction: Total pancreatectomy is the treatment of choice for multiple tumor locations in the pancreas, especially when it comes to the multifocal association of different lesions. Case Presentation: We report the case of a 62-year-old woman who underwent a complete pancreatectomy with spleen preservation for distal cholangiocarcinoma synchronous with multifocal IPMNs and a neuroendocrine tumor of the pancreas. Discussion: In the presence of a diffuse disease of the pancreas and/or in the case of tumor association, total pancreatectomy remains the only valid oncological option. Conclusion: Total pancreatectomy can be performed safely and without added risk in the presence of multiple or multifocal lesions of the pancreas.

Keywords:

Total pancreatectomy; Multifocal lesions; TIPMN; Distal cholangiocarcinoma

Cite the Article:

Lamara A, Nini B, Boukhane M, Ahmed Medjahdi S, Soualmia A, Rehamnia A, et al. Total Pancreatectomy with Spleen Preservation for Distal Cholangiocarcinoma Synchronous with Multifocal IPMNs and a Neuroendocrine Tumour of the Pancreas. Clin Oncol. 2020; 5: 1712.

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

High CDX2 Expression Predicts a Favorable Prognosis in Patients with Early-Stage Gastric Adenocarcinoma
 Abstract  PDF  Full Text
Identification of MicroRNAs as New Blood Biomarkers to Predict Breast Cancer Recurrence
 Abstract  PDF  Full Text
View More...